Heron Therapeutics, Inc. Profile Avatar - Palmy Investing

Heron Therapeutics, Inc.

Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a …

Biotechnology
US, San Diego [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Heron Therapeutics, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Heron Therapeutics, Inc. can't present revenue by segment

End of HRTX's Analysis
CIK: 818033 CUSIP: 427746102 ISIN: US4277461020 LEI: - UEI: -
Secondary Listings
HRTX has no secondary listings inside our databases.